Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ
-
* Corresponding author: Jeffrey P Gregg jpgregg@ucdavis.edu
Breast Cancer Research 2005, 7:R881-R889 doi:10.1186/bcr1317
Accesses
- Last 30 days: 41 accesses
- Last year: 585 accesses
- All time: 5239 accesses
Cited by
BioMed Central: 1 citation
|
Heterogeneity of mammary lesions represent molecular differences Ruria Namba, Jeannie E Maglione, Ryan R Davis, Colin A Baron, Stephenie Liu, Condie E Carmack, Lawrence JT Young, Alexander D Borowsky, Robert D Cardiff, Jeffrey P Gregg BMC Cancer 2006, 6:275 (5 December 2006) |